Literature DB >> 28991828

Pediatric Sepsis Endotypes Among Adults With Sepsis.

Hector R Wong1,2, Timothy E Sweeney3,4, Kimberly W Hart5, Purvesh Khatri3,4, Christopher J Lindsell5.   

Abstract

OBJECTIVES: Recent transcriptomic studies describe two subgroups of adults with sepsis differentiated by a sepsis response signature. The implied biology and related clinical associations are comparable with recently reported pediatric sepsis endotypes, labeled "A" and "B." We classified adults with sepsis using the pediatric endotyping strategy and the sepsis response signature and determined how endotype assignment, sepsis response signature membership, and age interact with respect to mortality.
DESIGN: Retrospective analysis of publically available transcriptomic data representing critically ill adults with sepsis from which the sepsis response signature groups were derived and validated.
SETTING: Multiple ICUs. PATIENTS: Adults with sepsis.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Transcriptomic data were conormalized into a single dataset yielding 549 unique cases with sepsis response signature assignments. Each subject was assigned to endotype A or B using the expression data for the 100 endotyping genes. There were 163 subjects (30%) assigned to endotype A and 386 to endotype B. There was a weak, positive correlation between endotype assignment and sepsis response signature membership. Mortality rates were similar between patients assigned endotype A and those assigned endotype B. A multivariable logistic regression model fit to endotype assignment, sepsis response signature membership, age, and the respective two-way interactions revealed that endotype A, sepsis response signature 1 membership, older age, and the interactions between them were associated with mortality. Subjects coassigned to endotype A, and sepsis response signature 1 had the highest mortality.
CONCLUSIONS: Combining the pediatric endotyping strategy with sepsis response signature membership might provide complementary, age-dependent, biological, and prognostic information.

Entities:  

Mesh:

Year:  2017        PMID: 28991828      PMCID: PMC5693699          DOI: 10.1097/CCM.0000000000002733

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  9 in total

1.  Adjusting batch effects in microarray expression data using empirical Bayes methods.

Authors:  W Evan Johnson; Cheng Li; Ariel Rabinovic
Journal:  Biostatistics       Date:  2006-04-21       Impact factor: 5.899

2.  Simplification of a Septic Shock Endotyping Strategy for Clinical Application.

Authors:  Hector R Wong; Timothy E Sweeney; Christopher J Lindsell
Journal:  Am J Respir Crit Care Med       Date:  2017-01-15       Impact factor: 21.405

3.  Validation of a gene expression-based subclassification strategy for pediatric septic shock.

Authors:  Hector R Wong; Natalie Z Cvijanovich; Geoffrey L Allen; Neal J Thomas; Robert J Freishtat; Nick Anas; Keith Meyer; Paul A Checchia; Richard Lin; Thomas P Shanley; Michael T Bigham; Derek S Wheeler; Lesley A Doughty; Ken Tegtmeyer; Sue E Poynter; Jennifer M Kaplan; Ranjit S Chima; Erika Stalets; Rajit K Basu; Brian M Varisco; Frederick E Barr
Journal:  Crit Care Med       Date:  2011-11       Impact factor: 7.598

4.  Toward a clinically feasible gene expression-based subclassification strategy for septic shock: proof of concept.

Authors:  Hector R Wong; Derek S Wheeler; Ken Tegtmeyer; Sue E Poynter; Jennifer M Kaplan; Ranjit S Chima; Erika Stalets; Rajit K Basu; Lesley A Doughty
Journal:  Crit Care Med       Date:  2010-10       Impact factor: 7.598

5.  Immunology. Getting sepsis therapy right.

Authors:  Richard S Hotchkiss; Edward R Sherwood
Journal:  Science       Date:  2015-03-13       Impact factor: 47.728

6.  Developing a clinically feasible personalized medicine approach to pediatric septic shock.

Authors:  Hector R Wong; Natalie Z Cvijanovich; Nick Anas; Geoffrey L Allen; Neal J Thomas; Michael T Bigham; Scott L Weiss; Julie Fitzgerald; Paul A Checchia; Keith Meyer; Thomas P Shanley; Michael Quasney; Mark Hall; Rainer Gedeit; Robert J Freishtat; Jeffrey Nowak; Raj S Shekhar; Shira Gertz; Emily Dawson; Kelli Howard; Kelli Harmon; Eileen Beckman; Erin Frank; Christopher J Lindsell
Journal:  Am J Respir Crit Care Med       Date:  2015-02-01       Impact factor: 21.405

7.  Shared and Distinct Aspects of the Sepsis Transcriptomic Response to Fecal Peritonitis and Pneumonia.

Authors:  Katie L Burnham; Emma E Davenport; Jayachandran Radhakrishnan; Peter Humburg; Anthony C Gordon; Paula Hutton; Eduardo Svoren-Jabalera; Christopher Garrard; Adrian V S Hill; Charles J Hinds; Julian C Knight
Journal:  Am J Respir Crit Care Med       Date:  2017-08-01       Impact factor: 21.405

8.  Identification of pediatric septic shock subclasses based on genome-wide expression profiling.

Authors:  Hector R Wong; Natalie Cvijanovich; Richard Lin; Geoffrey L Allen; Neal J Thomas; Douglas F Willson; Robert J Freishtat; Nick Anas; Keith Meyer; Paul A Checchia; Marie Monaco; Kelli Odom; Thomas P Shanley
Journal:  BMC Med       Date:  2009-07-22       Impact factor: 8.775

9.  Genomic landscape of the individual host response and outcomes in sepsis: a prospective cohort study.

Authors:  Emma E Davenport; Katie L Burnham; Jayachandran Radhakrishnan; Peter Humburg; Paula Hutton; Tara C Mills; Anna Rautanen; Anthony C Gordon; Christopher Garrard; Adrian V S Hill; Charles J Hinds; Julian C Knight
Journal:  Lancet Respir Med       Date:  2016-02-23       Impact factor: 102.642

  9 in total
  15 in total

Review 1.  Diagnosing and Managing Sepsis by Probing the Host Response to Infection: Advances, Opportunities, and Challenges.

Authors:  Ian L Gunsolus; Timothy E Sweeney; Oliver Liesenfeld; Nathan A Ledeboer
Journal:  J Clin Microbiol       Date:  2019-06-25       Impact factor: 5.948

Review 2.  Precision medicine in pediatric sepsis.

Authors:  Mihir R Atreya; Hector R Wong
Journal:  Curr Opin Pediatr       Date:  2019-06       Impact factor: 2.856

3.  Identifying Novel Sepsis Subphenotypes Using Temperature Trajectories.

Authors:  Sivasubramanium V Bhavani; Kyle A Carey; Emily R Gilbert; Majid Afshar; Philip A Verhoef; Matthew M Churpek
Journal:  Am J Respir Crit Care Med       Date:  2019-08-01       Impact factor: 21.405

4.  Sepsis Subclasses: A Framework for Development and Interpretation.

Authors:  Kimberley M DeMerle; Derek C Angus; J Kenneth Baillie; Emily Brant; Carolyn S Calfee; Joseph Carcillo; Chung-Chou H Chang; Robert Dickson; Idris Evans; Anthony C Gordon; Jason Kennedy; Julian C Knight; Christopher J Lindsell; Vincent Liu; John C Marshall; Adrienne G Randolph; Brendon P Scicluna; Manu Shankar-Hari; Nathan I Shapiro; Timothy E Sweeney; Victor B Talisa; Benjamin Tang; B Taylor Thompson; Ephraim L Tsalik; Tom van der Poll; Lonneke A van Vught; Hector R Wong; Sachin Yende; Huiying Zhao; Christopher W Seymour
Journal:  Crit Care Med       Date:  2021-05-01       Impact factor: 7.598

5.  Refining the Syndrome.

Authors:  Lincoln S Smith; Anoopindar Bhalla; Nadir Yehya
Journal:  Pediatr Crit Care Med       Date:  2020-12       Impact factor: 3.971

6.  Murine sepsis phenotypes and differential treatment effects in a randomized trial of prompt antibiotics and fluids.

Authors:  Christopher W Seymour; Samantha J Kerti; Anthony J Lewis; Jason Kennedy; Emily Brant; John E Griepentrog; Xianghong Zhang; Derek C Angus; Chung-Chou H Chang; Matthew R Rosengart
Journal:  Crit Care       Date:  2019-11-28       Impact factor: 9.097

Review 7.  Pediatric sepsis biomarkers for prognostic and predictive enrichment.

Authors:  Hector R Wong
Journal:  Pediatr Res       Date:  2021-06-14       Impact factor: 3.953

8.  External Corroboration That Corticosteroids May Be Harmful to Septic Shock Endotype A Patients.

Authors:  Hector R Wong; Kimberly W Hart; Christopher J Lindsell; Timothy E Sweeney
Journal:  Crit Care Med       Date:  2021-01-01       Impact factor: 9.296

Review 9.  Arguing for Adaptive Clinical Trials in Sepsis.

Authors:  Victor B Talisa; Sachin Yende; Christopher W Seymour; Derek C Angus
Journal:  Front Immunol       Date:  2018-06-28       Impact factor: 7.561

Review 10.  Sepsis therapies: learning from 30 years of failure of translational research to propose new leads.

Authors:  Jean-Marc Cavaillon; Mervyn Singer; Tomasz Skirecki
Journal:  EMBO Mol Med       Date:  2020-03-16       Impact factor: 12.137

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.